Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis

Kathryn E McDougal1, Deanna M Green, Lori L Vanscoy

  • 1McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.